Abstract
Adrenocortical carcinoma is a rare cancer that historically has been associated with poor outcome. Throughout the past decades, growing experience has allowed better understanding of the natural history and optimal management of this cancer. Advances in imaging and aggressive surgical therapy have raised the outlook for recently diagnosed patients. Further improvements in survival will require more effective systemic therapy.
Similar content being viewed by others
References and Recommended Reading
Icard P, Goudet P, Charpenay C, et al.: Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 2001, 25:891–897.
Kendrick ML, Lloyd R, Erickson L, et al.: Adrenocortical carcinoma: surgical progress or status quo? Arch Surg 2001, 136:543–549.
National Cancer Institute: Third National Cancer Survey Incidence Data. Bethesda, MD: National Cancer Institute; 1975:785–787.
Wooten MD, King DK: Adrenal cortical carcinoma: epidemiology and treatment with mitotane and a review of the literature. Cancer 1993, 72:3145–3155.
Bukowski RM, Klein EA: Adrenal neoplasms. In Comprehensive Textbook of Genitourinary Oncology. Edited by Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS. Philadelphia: Lippincott, Williams & Wilkins; 2000:1073–1101.
Wajchenberg BL, Pereira MA, Medonca BB, et al.: Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000, 88:711–736.
Brennan MF: Adrenocortical carcinoma. CA Cancer J Clin 1987, 37:348–365.
King DR, Lack EE: Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases. Cancer 1979, 44:239–244.
Hogan TF, Gilchrist KW, Westring DW, Citrin DL: A clinical and pathological study of adrenocortical carcinoma: therapeutic implications. Cancer 1980, 45:2880–2883.
Karakousis CP, Rao V, Moore, R: Adrenal adenocarcinomas: histologic grading survival. J Surg Oncol 1985, 29:105–111.
Bodie B, Novick AC, Pontes, JE, et al.: The Cleveland Clinic experience with adrenal cortical carcinoma. J Urol 1989, 141:257–260.
Luton JP, Cerda S, Billaud L, et al.: Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990, 322:1195–1201.
Schulick RD, Brennan MF: Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 1999, 6:719–726.
Favia G, Lumachi F, D’Amico DF: Adrenocortical carcinoma: Is prognosis different in nonfunctioning tumors? Results of surgical treatment in 31 patients. World J Surg 2001, 25:735–738.
Mantero F, Terzolo M, Arnaldi G, et al.: A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 2000, 85:637–644. Large review of the clinical significance of the incidental adrenal mass with probable findings and outcomes described.
Kasperlik-Zeluska AA, Roslonowska E, Slowinska-Srzednicka J, et al.: Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf) 1997,46:29–37.
Bulow B, Ahren B, Swedish Research Council Study Group of Endocrine Abdominal Tumours: Adrenal incidentaloma: experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 2002, 252:239–246.
MacFarlane DA: Cancer of the adrenal cortex: the natural history, prognosis, and treatment in a study of fifty-five cases. Ann R Coll Surg Engl 1958, 23:155–186.
Norton JA, Le HN: Adrenal tumors. In Cancer: Principles and Practice of Oncology. Edited by DeVita VT, Hellman S, Rosenberg SA. Philadelphia: Lippincott, Williams & Wilkins; 2001:1770–1788.
Venkatesh S, Hickey RC, Sellin RV, et al.: Adrenal cortical carcinoma. Cancer 1989,64:765–769.
Grondal S, Cedermark B, Eriksson B, et al.: Adrenocortical carcinoma: a retrospective study of a rare tumor with a poor prognosis. Eur J Surg Oncol 1990,16:500–506.
Soreide JA, Brabrand K, Thoresen SO: Adrenal cortical carcinoma in Norway, 1970–1984. World J Surg 1992, 16:663–668.
Pommier RF, Brennan MF: An 11-year experience with adrenocortical carcinoma. Surgery 1992, 112:963–970.
Zografos GC, Driscoll DL, Karakousis CP, Huben, RP: Adrenal adenocarcinoma: a review of 53 cases. J Surg Oncol 1994, 55:160–164.
Haak HR, Hermans J, de van Velde CJ, et al.: Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer 1994, 69:947–951.
Bellantone R, Ferrante A, Boscherini M, et al.: Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery 1997, 122:1218–1218.
Eddy RL, Jones AL, Gilliland PF, et al.: Cushing’s syndrome: a prospective study of diagnostic methods. Am J Med 1973, 55:621–630.
Korobkin M, Francis IR: Imaging of adrenal masses. Urol Clin North Am 1997, 24:603–622.
Kouriefs C, Mokbel K, Choy C: Is MRI more accurate than CT in estimating the real size of adrenal tumours? Eur J Surg Oncol 2001, 27:487–490.
Godellas CV, Prinz RA: Surgical approaches to adrenal neoplasms: Laparoscopic versus open adrenalectomy. Surg Oncol Clin North Am 1998, 7:807–817.
Wells SA, Merke DP, Cutler GB, et al.: Therapeutic controversy: the role of laparoscopic surgery in adrenal disease. J Clin Endocrinol Metab 1998, 83:3041–3049.
Gill IS: The case for laparoscopic adrenalectomy. J Urol 2001, 166:429–436.
Hobart MG, Gill IS, Schweizer D, et al.: Laparoscopic adrenalectomy for large-volume (bd> or = 5 cm) adrenal masses. J Endourol 2000, 14:149–154.
Kebebew E, Siperstein AE, Clark OH, Duh QY: Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms. Arch Surg 2002, 137:948–949. Provides strong evidence justifying the laparoscopic approach for malignant adrenal tumors when complete resection is feasible; demonstrates outcome that is comparable with open surgery.
Bergenstal DM, Hertz R, Lipsett MB, Moy RH: Chemotherapy of adrenocortical cancer with o,p’-DDD. Ann Intern Med 1960, 53:672–684.
Boven E, Vermorken JB, vanSlooten H, Pinedo HM: Complete response of metastasized adrenal cortical carcinoma with o,p’-DDD: case report and literature review. Cancer 1984, 55:26–29.
Terzolo M, Pia A, Berruti A, Osella G: Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effect in patients with adrenocortical cancer. J Clin Endocrinol Metab 2000, 85:2234–2238.
Markoe AM, Serber W, Micaily B, Brady LW: Radiation therapy for adjunctive treatment of adrenal cortical carcinoma. Am J Clin Oncol 1991, 14:170–174.
Percarpio B, Knowlton AH: Radiation therapy of adrenal cortical carcinoma. Acta Radiol Ther Phys Biol 1976, 15:288–292.
Jossart GH, Shibuya K, Gagner M: Laparoscopic cryotherapy of the liver, pancreas, and adrenal gland. Surg Technol Int 2000, 8:195–109.
Wood BJ, Abraham J, Hvizda JL, et al.: Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 2003, 97:554–560.
Regge D, Balma E, Lasciarrea P, et al.: Interventional radiology of the adrenal glands. Minera Endocrinol 1995, 20:15–26.
Tang CK, Gray GF: Adrenocortical neoplasms: prognosis and morphology. Urology 1975, 5:691–695.
Weiss LM, Medeiros LJ, Vickery AL: Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1989, 13:202–206.
Barnett CC, Varma DG, El-Naggar AK, et al.: Limitations of size as a criterion in the evaluation of adrenal tumors. Surgery 2000, 128:973–982.
Weiss LM: Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984, 8:163–169.
Stojadinovic A, Ghossein RA, Hoos A, et al.: Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 2002, 4:941–950. A detailed analysis of morphologic and histopathologic characteristics of adrenocortical tumors; it correlates the significance of various parameters to outcome and establishes criteria for stratification of patients into prognostic groups.
Wieneke JA, Thompson LDR, Heffess CS: Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. Am J Surg Pathol 2003, 27:867–881. A comprehensive clinical and pathologic characterization of adrenocortical carcinoma in a large pediatric population. This study describes the different behavior of pediatric tumors and proposes prognostic criteria to suggest malignancy.
Lo CY, van Heerden JA, Soreide JA, et al.: Adrenalectomy for metastatic disease to the adrenal glands. Br J Surg 1996, 84:528–531.
Kim SH, Brennan MF, Russo P, et al.: The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer 1998, 82:389–394.
Lenert JT, Barnett CC, Kudelka AP, et al.: Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery 2001, 130:1060–1067.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, D.Y.T., Sosa, R.E. & Scherr, D.S. Treatment of adrenocortical carcinoma: Contemporary outcomes. Curr Urol Rep 5, 65–72 (2004). https://doi.org/10.1007/s11934-004-0014-x
Issue Date:
DOI: https://doi.org/10.1007/s11934-004-0014-x